Individual optimal dose of amrubicin to prevent severe neutropenia in Japanese patients with lung cancer

This study determined individual optimal amrubicin doses for Japanese patients with lung cancer after platinum‐based treatment. We carried out population pharmacokinetic and pharmacodynamic modeling incorporating gene polymorphisms of metabolizing enzymes and transporters. Fifty patients with lung c...

Descripción completa

Detalles Bibliográficos
Autores principales: Makino, Yoshinori, Makihara‐Ando, Reiko, Ogawa, Takanori, Sato, Hitoshi, Goto, Yasushi, Kanda, Shintaro, Horinouchi, Hidehito, Fujiwara, Yutaka, Ohe, Yuichiro, Yamamoto, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825008/
https://www.ncbi.nlm.nih.gov/pubmed/31505087
http://dx.doi.org/10.1111/cas.14194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825008/
https://www.ncbi.nlm.nih.gov/pubmed/31505087
http://dx.doi.org/10.1111/cas.14194

Ejemplares similares